(S (NP (NP (DT The) (JJ automatic) (NN segmentation)) (PP (IN of) (NP (JJ retinal) (NN layer) (NNS structures)))) (VP (VBZ enables) (NP (NP (ADJP (JJ clinically-relevant)) (NN quantification) (CC and) (NN monitoring)) (PP (IN of) (NP (NN eye) (NNS disorders))) (PP (IN over) (NP (NN time))) (PP (IN in) (NP (NNP OCT) (NN imaging))))) (. .))
(S (NP (NP (NNS Eyes)) (PP (IN with) (NP (JJ late-stage) (NNS diseases)))) (VP (VBP are) (ADJP (RB particularly) (VBG challenging) (SBAR (S (VP (TO to) (VP (NN segment)))))) (, ,) (SBAR (IN as) (S (NP (PRP$ their) (NN shape)) (VP (VBZ is) (ADJP (RB highly) (JJ warped)) (PP (JJ due) (PP (TO to) (NP (JJ pathological) (NNS biomarkers)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN context))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN novel) (ADJP (RB fully) (NNP Convolutional)) (NNP Neural) (NNP Network) (PRN (-LRB- -LRB-) (NNP CNN) (-RRB- -RRB-)) (NN architecture)) (SBAR (WHNP (WDT which)) (S (VP (VP (NNS combines) (NP (VBD dilated) (JJ residual) (NNS blocks)) (PP (IN in) (NP (DT an) (JJ asymmetric) (NN U-shape) (NN configuration)))) (, ,) (CC and) (VP (MD can) (VP (NN segment) (NP (NP (JJ multiple) (NNS layers)) (PP (IN of) (NP (ADJP (RB highly) (JJ pathological)) (NNS eyes)))) (PP (IN in) (NP (CD one) (NN shot)))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP validate) (NP (PRP$ our) (NN approach)) (PP (IN on) (NP (NP (DT a) (NN dataset)) (PP (IN of) (NP (JJ late-stage) (NNP AMD) (NNS patients)))))) (CC and) (VP (VB demonstrate) (NP (NP (NP (JJR lower) (NN computational) (NNS costs)) (CC and) (NP (JJR higher) (NN performance))) (PP (VBN compared) (PP (TO to) (NP (JJ other) (JJ state-of-the-art) (NNS methods))))))) (. .))
